Peroxisome proliferator-activated receptors increase human sebum production

Journal of Investigative Dermatology

Volumn 126, Issue 9, 2006, Pages 2002-2009

  Trivedi, Nishit R ^a   Cong, Zhaoyuan ^a   Nelson, Amanda M ^a   Albert, Adam J ^b   Rosamilia, Lorraine L ^b   Sivarajah, Surendra ^b   Gilliland, Kathryn L ^a   Liu, Wenlei ^c   Mauger, David T ^c   Gabbay, Robert A ^b   Thiboutot, Diane M ^a,b  

^a PENN STATE CANCER INSTITUTE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c Department of Dermatology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETIC ACID; CARBON 14; FIBRIC ACID DERIVATIVE; GW 0072; GW 0742; GW 2433; GW 4148; GW 7647; ISOTRETINOIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ACNE; ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LIPOGENESIS; MALE; PRIORITY JOURNAL; SEBUM; SEBUM SECRETION; SKIN;

ADULT; ANTILIPEMIC AGENTS; CELL LINE, TRANSFORMED; DIABETES MELLITUS; FEMALE; GEMFIBROZIL; HUMANS; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; ISOTRETINOIN; LIGANDS; LIPOGENESIS; MALE; MIDDLE AGED; PPAR ALPHA; PPAR GAMMA; PROCETOFEN; SEBACEOUS GLANDS; SEBUM; THIAZOLIDINEDIONES;

EID: 33747330860     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700336     Document Type: Article

References (38)

1. Alestas T, Ganceviciene R, Fimmel S, Muller-Decker K, Zouboulis C (2006) Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med 84:75-87
2. Berger J, Moller DE (2002) The mechanisms of action of PPARs. Annu Rev Med 53:409-35
3. Billoni N, Buan B, Gautier B, Collin C, Gaillard O, Mahe YF et al. (2000) Expression of peroxisome proliferator activated receptors (PPARs) in human hair follicles and PPAR alpha involvement in hair growth. Acta Derm Venereol 80:329-34
4. Boyle PJ, King AB, Olansky L, Marchetti A, Lau H, Magar R et al. (2002) Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records. Clin Ther 24:378-96
5. Braissant O, Scotto FFC, Dauca M, Wahli W (1996) Defferential expression of peroxisome proliferator-activated receptor (PPAR): tissue distribution of PPAR-α,-β, and -γ in the adult rat. Endocrinology 137:354-66
6. Chen W, Yang C, Sheu H, Seltmann H, Zouboulis C (2003) Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 121:441-7
7. Desvergne B, Michalik L, Wahli W (2004) Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol Endocrinol 18:1321-32
8. Downie MM, Sanders D, Maier L, Stock D, Kealey T (2004) Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaeous gland organ cultures in vitro. Br J Dermatol 151:766-75
9. Fazio S, Linton MF (2004) The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy. Curr Atheroscler Rep 6:148-57
10. Ferre P (2004) The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53(Supp 1):S43-50
11. Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA et al. (2005) A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabet Care 28:1547-54
12. Iwata C, Akimoto N, Sato T, Morokuma Y, Ito A. (2005) Augmentation of lipogenesis by 15-deoxy-Delta12,14-prostaglandin J2 in hamster sebaceous glands: identification of cytochrome P-450-mediated 15-deoxy-Delta12,14-prostaglandin J2 production. J Invest Dermatol 125:865-72
13. Khan MA, St Peter JV, Xue JL (2002) A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone. Diabet Care 25:708-11
14. Kim MJ, Deplewski D, Ciletti N, Michel S, Reichert U, Rosenfield RL (2001) Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development. Mol Genet Metab 74:362-9
15. Knouff C, Auwerx J (2004) Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology. Endocr Rev 25:899-918
16. Mao-Qiang M, Fowler A, Schmuth M, Lau P, Chang S, Brown B et al. (2004) Peroxisome proliferator-activated receptor (PPAR)-γ activation stimulates keratinocyte differentiation. J Invest Dermatol 123:305-12
17. Motojima K, Passilly P, Peters J, Gonzalez F, Latruffe N (1998) Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue- and inducer-specific manner. J Biol Chem 273:16710-4
18. Oberfield JL, Collins JL, Holmes CP, Goreham DM, Cooper JP, Cobb JE et al. (1999) A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. Proceedings of the National Academy of Sciences of the United States of America 96:6102-6
19. Rival Y, Stennevin A, Puech L, Rouquette A, Cathala C, Lestienne F et al. (2004) Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands. J Pharmacol Exp Ther 311:467-75
20. Rivier M, Safanova I, Lebrun P, Griffiths C, Ailhaud G, Michel S (1998) Differential expression of peroxisome proliferator-activated receptor subtypes during differentiation of human keratinocytes. J Invest Dermatol 111:1116-21
21. Rosen ED, Spiegelman BM (2001) PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276:37731-4
22. Rosenfield RL, Deplewski D, Greene ME (2000) Peroxisome proliferator-activated receptors and skin development. Horm Res 54:269-74
23. Rosenfield RL, Deplewski D, Kentsis A, Ciletti N (1998) Mechanisms of androgen induction of sebocyte differentiation. Dermatology 196:43-6
24. Rosenfield RL, Kentsis A, Deplewski D, Ciletti N (1999) Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. J Invest Dermatol 112:226-32
25. Sandouk T, Reda D, Hofmann C (1993) The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability. Endocrinology 133:352-9
26. Schmuth M, Haqq C, Cairns W, Holder J, Dorsam S, Chang S et al. (2004) Peroxisome proliferator-activated receptor (PPAR)-β/δ stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 122:971-83
27. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S et al. (1996) PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15:5336-48
28. Smith TM, Cong Z, Gilliland KL, Clawson GA, Thiboutot DM (2006) Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element binding protein-1. J Invest Dermatol 126:1226-32
29. Thiboutot D, Jabara S, McAllister J, Sivarajah A, Gilliland K, Cong Z et al. (2003) Human skin is a steroidogenic tissue: Steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol 120:905-14
30. van Raalte DH, Li M, Pritchard PH, Wasan KM (2004) Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future. Pharm Res 21:1531-8
31. Westergaard M, Henningsen J, Svendsen M, Johansen C, Jensen U, Schroder H et al. (2001) Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J Invest Dermatol 116:702-12
32. Zouboulis C, Korge B, Akamatsu H, Xia L, Schiller S, Gollnick H et al. (1991) Effects of 13-cis-retinoic acid, all-trans-retinoic acid, and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Invest Dermatol 96:792-7
33. Zouboulis CC (2004) Acne and sebaceous gland function. Clin Dermatol 22:360-6
34. Zouboulis CC (2001) Is acne vulgaris a genuine inflammatory disease? Dermatology 203:277-9
35. Zouboulis CC, Degitz K (2004) Androgen action on human skin - from basic research to clinical significance. Exp Dermatol 13(Suppl 4):5-10
36. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC et al. (2005) What is the pathogenesis of acne? Exp Dermatol 14:143-52
37. Zouboulis CC, Nestoris S, Adler YD, Orth M, Orfanos CE, Picardo M et al. (2003) A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 139:668-70
38. Zouboulis Ch C, Saborowski A, Boschnakow A (2005) Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 210:36-8